Chagas disease and its causative agent Trypanosoma cruzi are endemic in almost all
countries in South and Middle America. Currently, there are more than 10 million affected …

Parasitic infections are a relatively uncommon complication in solid organ transplant (SOT)
recipients in the United States. In addition, parasitic infections are also rare in the general …

Chagas disease, which is caused by the protozoan parasite Trypanosoma cruzi, can lead to
severe cardiac and gastrointestinal disease. Most persons acquire this infection through …

Introduction Chagas cardiomyopathy, a disease caused by Trypanosoma cruzi (T. cruzi)
infection, is a major contributor to heart failure in Latin America. There are significant gaps in …

American trypanosomiasis, also named Chagas disease (CD), is an anthropozoonosis
caused by the protozoan parasite Trypanosoma cruzi. The disease affects millions of people …

Background Chagas disease (CD) continues to be a neglected infectious disease with one
of the largest burdens globally. Despite the modest cure rates in adult chronic patients and …

Chagas disease (CD) affects approximately 6–7 million people worldwide, from which 30%
develop chronic Chagas cardiomyopathy (CCC), usually after being asymptomatic for years …

Predictors of all-cause 1-year mortality in myocardial infar... : Medicine Predictors of all-cause
1-year mortality in myocardial infarction patients : Medicine Log in or Register Get new issue …

The discovery of new antiparasitic compounds against Trypanosoma cruzi, the etiological
agent of Chagas disease, is necessary. Novel aryloxy/aryl thiosemicarbazone-based …

In previous studies, the compound 3-(bromopropiophenone) thiosemicarbazone was
described as a potent anti-Trypanosoma cruzi and cruzain inhibitor. In view to optimize this …